Pharma is spending millions to prepare for the Sunshine Act. But with disclosure likely to drive negative press, drug firms should consider changing the way they pay doctors for speaking, travel and meals
In response to seismic forces that are buffeting the US medical marketplace, most pharma companies are phasing in new commercial models that, among other things, revamp how sales forces are deployed.